The risk that strengthened regulations under the Act on the Conservation and Sustainable Use of Biological Diversity through Regulations on the Use of Living Modified Organisms, which apply to facilities handling recombinant proteins, will create additional compliance burdens and restrictions on facility operations and research and manufacturing activities.